Expert Review of Vaccines logo Expert Reviews logo

Expert Review of Vaccines provides expert reviews on the clinical effectiveness of new vaccines. Coverage includes vaccine technology, vaccine adjuvants, prophylactic vaccines, therapeutic vaccines, AIDS vaccines and vaccines in bioterrorism.

Publisher: Expert Reviews

Volume 4, Number 3, June 2005
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial

Regulatory pathways for developing market vaccines redux
pp. 241-243(3)
Author: Milstien, Julie B

News in Brief

News in Brief
pp. 245-246(2)

Trial Watch

Trial Watch
pp. 247-248(2)

Vaccine Profile

Vaccination with BLP25 liposome vaccine to treat non-small cell lung and prostate cancers
pp. 249-257(9)
Authors: North, Scott; Butts, Charles

Vaccines in cancer: GVAX®, a GM-CSF gene vaccine
pp. 259-274(16)
Author: Nemunaitis, John

Perspective

Developing vaccines to counter bioterrorist threats
pp. 275-279(5)
Author: Altmann, Daniel M

Vaccine presentations and delivery technologies – what does the future hold?
pp. 281-287(7)
Authors: Clements, C John; Wesselingh, Steve L

Review

Clinical experience with therapeutic AIDS vaccines
pp. 289-304(16)
Authors: Bourinbaiar, Aldar S; Abulafia-Lapid, Rivka

HIV vaccines: brief review and discussion of future directions
pp. 305-313(9)
Authors: Slobod, Karen S; Bonsignori, Mattia; Brown, Scott A; Zhan, Xiaoyan; Stambas, John; Hurwitz, Julia L

Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens
pp. 315-327(13)
Authors: Pavlenko, Maxim; Leder, Christoph; Pisa, Pavel

Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials
pp. 329-350(22)
Authors: Mosolits, Szilvia; Nilsson, Bo; Mellstedt, Håkan

Development of prophylactic and therapeutic vaccines against hepatitis C virus
pp. 351-371(21)
Author: Leroux-Roels, Geert

Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?
pp. 373-379(7)
Author: Gorringe, Andrew R

Progress toward an elusive goal: current status of cytomegalovirus vaccines
pp. 381-406(26)
Authors: Schleiss, Mark R; Heineman, Thomas C

Information technologies for vaccine research
pp. 407-417(11)
Authors: Brusic, Vladimir; August MD, J Thomas; Petrovsky, Nikolai

Fever following immunization
pp. 419-427(9)
Authors: Tapiainen, Terhi; Heininger, Ulrich

Filovirus-like particles as vaccines and discovery tools
pp. 429-440(12)
Authors: Warfield, Kelly L; Swenson, Dana L; Demmin, Gretchen; Bavari, Sina

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A